Table 3 comorbidities with COVID-19 mortality
Disease | Abundance | Percent frequency | P-value |
|---|---|---|---|
Absence of disease | 2762 | 28.8 | 0.000 |
Diabetes | 2730 | 28.4 | |
Hypertension | 1233 | 12.8 | |
Cardiovascular | 1031 | 10.7 | |
Chronic pulmonary disease | 379 | 3.9 | |
Kidney | 363 | 3.8 | |
Stroke | 247 | 2.6 | |
Obesity | 116 | 1.2 | |
Chronic neurology | 106 | 1.1 | |
TSH/T4 | 78 | 0.8 | |
Reduced blood platelets | 62 | 0.6 | |
Leukemia | 59 | 0.6 | |
Chronic Hepatic | 52 | 0.5 | |
Addiction | 46 | 0.5 | |
IHD | 37 | 0.4 | |
Breast cancer | 36 | 0.4 | |
Pregnancy | 36 | 0.4 | |
Hypothyroidism | 34 | 0.4 | |
Lung cancer | 33 | 0.3 | |
Prostate cancer | 27 | 0.3 | |
Bone marrow cancer | 23 | 0.2 | |
Clone cancer | 16 | 0.2 | |
Gastric cancer | 13 | 0.1 | |
Lymphoma cancer | 11 | 0.1 | |
Laryngeal cancer | 10 | 0.1 | |
Bowel cancer | 10 | 0.1 | |
Skin cancer | 10 | 0.1 | |
HIV | 10 | 0.1 | |
Tb | 8 | 0.1 | |
Hepatitis B | 8 | 0.1 | |
Lupus | 8 | 0.1 | |
Uterine and ovarian cancer | 6 | 0.1 | |
Bladder cancer | 6 | 0.1 | |
Esophageal cancer | 5 | 0.1 | |
HCV | 5 | 0.1 |